

David B. Fournier
- Chicago
Notice
Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.
Dave brings both academic training and 25 years of professional experience to his guidance on patent prosecution and portfolio development.
David Fournier advises clients on pharmaceutical, biologic, medical device, and consumer product patent matters. He emphasizes product exclusivity planning, strategic development of global patent portfolios, and counseling related to pharmaceutical products under the Drug Price Competition and Patent Term Restoration (Hatch-Waxman) Act and biologics therapies under the Public Health Service Act and the Biologics Price Competition and Innovation Act.
Dave has guided patent portfolio development and lifecycle management strategies for a variety of U.S. Food and Drug Administration (FDA)-approved drugs, including Vascepa®, Androgel®, Celebrex®, Zegerid®, Inspra®, and Detrol®, as well as FDA-approved devices, including Cortrak®, Navigator®, and Corflo®. He has developed patent portfolios for several developmental-stage biologics, including stem cell therapies, antibody-drug conjugates, and peptide conjugates.
Areas of focus
Education & Credentials
Education
- DePaul University College of Law, J.D., cum laude, 2003
- Northwestern University, M.S., Biotechnology, 1999
- Lake Forest College, B.A., Biology, cum laude, 1997
Bar and Court Admissions
-
Illinois
-
U.S. Patent and Trademark Office
- U.S. District Court for the Northern District of Illinois
Related Employment
- Pfizer Inc. (formerly Pharmacia Corp.), Patent Scientist and Patent Agent
Professional Recognition
Listed in Chambers USA "America's Leading Lawyers" for Intellectual Property, 2022-2024
Listed in The Best Lawyers in America: Patent Law; Biotechnology and Life Sciences Practice, 2022-2025
Recommended in Intellectual Asset Management Patent 1000, 2018-2024
Listed as an "Illinois Rising Star" by Illinois Law & Politics, 2012-2014
*The Supreme Court of Illinois does not recognize certifications of specialties in the practice of law and no certificate, award or recognition is a requirement to practice law in Illinois.